Who Paid My Doc
Edna Juarez
Internal Medicine Las Cruces, NM Medical Doctor
NPI 1770966699 CMS profile 4930900
2450 S. Telshor Blvd., Bldg. D., Suite 1, Las Cruces, NM 88011
General payments
$1,631
Research payments
$0
Ownership & investment interest
$0
Through program year 2022, Edna Juarez of Las Cruces, NM is reported in the CMS Open Payments database as having received $1,631 across 91 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 77th percentile of Internal Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
4 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2022 | General | $338 | 16 | |
| 2021 | General | $699 | 40 | |
| 2020 | General | $190 | 11 | |
| 2019 | General | $403 | 24 |
Beside peers
- Edna Juarez
- Internal Medicine median
- Middle half of Internal Medicine
- National median
In program year 2025, general payments to Edna Juarez were reported at $0. Among 52,115 Internal Medicine profiles paid that year, the median was $156 and the middle half received between $47 and $551.
Show as a table
| Year | Edna Juarez | Internal Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $403 | $159 | $48–$570 | $163 |
| 2020 | $190 | $119 | $33–$402 | $114 |
| 2021 | $699 | $135 | $37–$521 | $132 |
| 2022 | $338 | $141 | $42–$496 | $149 |
| 2023 | $0 | $149 | $45–$519 | $160 |
| 2024 | $0 | $154 | $47–$537 | $164 |
| 2025 | $0 | $156 | $47–$551 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 8 billing codesPaid by Medicare
$50,758
Medicare patients
216
Services billed
676
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 57% | |
| Chronic kidney disease | 46% | |
| Heart failure | 45% | |
| Diabetes | 44% | |
| Ischemic heart disease | 44% | |
| Atrial fibrillation | 39% | |
| COPD | 33% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
91 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Internal Medicine in New Mexico
Edward Lewiecki
Internal Medicine · Albuquerque, NM
James Adair
Internal Medicine · Albuquerque, NM
Gulshan Parasher
Internal Medicine · Albuquerque, NM
Mark Walker
Internal Medicine · Albuquerque, NM
Joao Teixeira
Internal Medicine · Albuquerque, NM
Karla Almaraz
Internal Medicine · Albuquerque, NM
Related records
Internal Medicine in New Mexico
Practitioners in the same specialty and state, ranked by reported value.
All Internal Medicine
Everyone recorded under this specialty, nationwide.
Doctors in New Mexico
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.